Skip to content
healthcare.dev

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

NDC 0093-5234, Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, tablet, film coated, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-5234
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5234 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFAVIRENZ600 mg/1
  • EMTRICITABINE200 mg/1
  • TENOFOVIR DISOPROXIL FUMARATE300 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Nucleosides [CS]

Package NDCNDC-11Package
0093-5234-560009352345630 TABLET, FILM COATED in 1 BOTTLE (0093-5234-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fc9c2149-8d40-401b-af13-5ae7f953950a
  • NADAC price for package 00093523456

    GET /v1/drugs/nadac/00093523456

Use it

Look up 0093-5234 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5234 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-5234. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.